Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke

Annals of Neurology

Volumn 64, Issue 4, 2008, Pages 402-409

  Gretarsdottir, Solveig ^a   Thorleifsson, Gudmar ^a   Manolescu, Andrei ^a   Styrkarsdottir, Unnur ^a   Helgadottir, Anna ^a   Gschwendtner, Andreas ^b   Kostulas, Konstantinos ^c   Kuhlenbäumer, Gregor ^d,e   Bevan, Steve ^f   Jonsdottir, Thorbjorg ^a   Bjarnason, Hjordis ^a   Saemundsdottir, Jona ^a   Palsson, Stefan ^a   Arnar, David O ^g   Holm, Hilma ^a   Thorgeirsson, Gudmundur ^g   Valdimarsson, Einar Mar ^g   Sveinbjörnsdottir, Sigurlaug ^g   Gieger, Christian ^h,i   Berger, Klaus ^d   Wichmann, H Erich ^h,i   Hillert, Jan ^c   Markus, Hugh ^f   Gulcher, Jeffrey Robert ^a   Ringelstein, E Bernd ^d   Kong, Augustine ^a   Dichgans, Martin ^b   Gudbjartsson, Daniel Fannar ^a   Thorsteinsdottir, Unnur ^a,j   Stefansson, Kari ^a,j   more..

^a DECODE GENETICS   (Iceland)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e UNIVERSITY OF KIEL   (Germany)

^f ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^g LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^h INSTITUTE OF EPIDEMIOLOGY   (Germany)

ⁱ UNIVERSITY OF MUNICH   (Germany)

^j UNIVERSITY OF ICELAND   (Iceland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHROMOSOME 4Q; CHROMOSOME 4Q25; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HEART ATRIUM FIBRILLATION; HUMAN; ICELAND; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ATRIAL FIBRILLATION; CHROMOSOMES, HUMAN, PAIR 4; CONFIDENCE INTERVALS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STROKE;

EID: 55849100349     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21480     Document Type: Article

References (31)

1. Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol 2007;6:182-187.
2. Hassan A, Markus HS. Genetics and ischaemic stroke. Brain 2000;123(pt 9):1784-1812.
3. Markus H. Genes for stroke. J Neurol Neurosurg Psychiatry 2004;75:1229-1231.
4. Flossmann E, Schulz UG, Rothwell PM. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 2004;35:212-227.
5. Brass LM, Isaacsohn JL, Merikangas KR, Robinette CD. A study of twins and stroke. Stroke 1992;23:221-223.
6. Jerrard-Dunne P, Cloud G, Hassan A, Markus HS. Evaluating the genetic component of ischemic stroke subtypes: a family history study. Stroke 2003;34:1364-1369.
7. Jousilahti P, Rastenyte D, Tuomilehto J, et al. Parental history of cardiovascular disease and risk of stroke. A prospective follow-up of 14371 middle-aged men and women in Finland. Stroke 1997;28:1361-1366.
8. Rubattu S, Volpe M, Kreutz R, et al. Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease. Nat Genet 1996;13:429-434.
9. Dichgans M. Genetics of ischaemic stroke. Lancet Neurol 2007;6:149-161.
10. Stroke - 1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke 1989;20:1407-1431.
11. Wichmann HE, Gieger C, Illig T. KORA-gen - resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 2005;67(suppl 1):S26-S30.
12. Berger K, Stogbauer F, Stoll M, et al. The glu298asp polymorphism in the nitric oxide synthase 3 gene is associated with the risk of ischemic stroke in two large independent case-control studies. Hum Genet 2007;121:169-178.
13. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
14. Kutyavin IV, Milesi D, Belousov Y, et al. A novel endonuclease IV post-PCR genotyping system. Nucleic Acids Res 2006;34:e128.
15. Gretarsdottir S, Thorleifsson G, Reynisdottir ST, et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet 2003;35:131-138.
16. Gudbjartsson DF, Arnar DO, Helgadottir A, et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007;448:353-357.
17. Devlin B, Roeder K. Genomic control for association studies. Biometrics 1999;55:997-1004.
18. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-748.
19. Faucourt M, Houliston E, Besnardeau L, et al. The pitx2 homeobox protein is required early for endoderm formation and nodal signaling. Dev Biol 2001;229:287-306.
20. Mommersteeg MT, Hoogaars WM, Prall OW, et al. Molecular pathway for the localized formation of the sinoatrial node. Circ Res 2007;100:354-362.
21. Barthelemy JC, Feasson-Gerard S, Garnier P, et al. Automatic cardiac event recorders reveal paroxysmal atrial fibrillation after unexplained strokes or transient ischemic attacks. Ann Noninvasive Electrocardiol 2003;8:194-199.
22. Jabaudon D, Sztajzel J, Sievert K, et al. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke 2004;35:1647-1651.
23. Ferro JM. Cardioembolic stroke: an update. Lancet Neurol 2003;2:177-188.
24. Murtagh B, Smalling RW. Cardioembolic stroke. Curr Atheroscler Rep 2006;8:310-316.
25. Lip GY, Lim HS. Atrial fibrillation and stroke prevention. Lancet Neurol 2007;6:981-993.
26. Wolf PA, Singer DE. Preventing stroke in atrial fibrillation. Am Fam Physician 1997;56:2242-2250.
27. Feinberg WM, Blackshear JL, Laupacis A, et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995;155:469-473.
28. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. Jama 2001;285:2370-2375.
29. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-988.
30. Lip GY, Boos CJ. Antithrombotic treatment in atrial fibrillation. Heart 2006;92:155-161.
31. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146:857-867.